-transparent.png){kind=logo}
Prediction of a recurrence of thyrotoxicosis during radioiodine therapy of patients with diffuse toxic goiter (DTG) is a pressing problem of everyday treatment of such patients. Altogether 43 DTG patients were investigated during 12-18 mos. after 131I therapy with the determination of T4, T3, bTSH, delta TSH in the TRH test, peripheral blood rosette forming (RFC), migration index (MI) in the leucocyte migration inhibition reaction, and serum immunoglobulins (IgA, M, G). Changes in the immunological status in parallel with confirmation of autonomous thyroid functioning suggested higher risk of a thyrotoxicosis recurrence making it possible to differentiate the type of observation of a DTG patient following radioiodine therapy. The availability of the above tests allows their use for the prediction of recurrences in everyday clinical practice during therapy of DTG patients with 131I.
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
March 1970,
Fel'dsher i akusherka,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
January 1976,
Ugeskrift for laeger,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
August 1948,
Boletim do Sanatorio Sao Lucas. Sao Paulo, Brazil (City) Sanatorio Sao Lucas,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
January 1981,
Problemy endokrinologii,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
February 1976,
Meditsinskaia radiologiia,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
January 1966,
Endokrynologia Polska,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
April 1975,
Vrachebnoe delo,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
July 1949,
Journal of the American Medical Association,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
September 1978,
Archives of internal medicine,
A S Ametov, and
A Kh Livshits, and
E K Oleĭnik
January 1977,
Problemy endokrinologii,
